Oral VK2735
Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)
Viking Therapeutics · Phase 3 · Not yet recruiting · Enrollment 560
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Placebo Assignment | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose 1) | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose 2) | n/r | n/r | n/r | n/r | n/r |
| Active Assignment (Dose 3) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.